"Designing Growth Strategies is in our DNA"

U.S. Dry Eye Syndrome Market Size, Share & COVID-19 Impact Analysis, By Product (Anti-inflammatory Products {Cyclosporin, Corticosteroids, and Others}, Artificial Tears and Lubricants, and Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI107538

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Dry Eye Disease in the U.S., 2022
    2. Key Industry Developments
    3. Pipeline Analysis
    4. New Product Launches
    5. Reimbursement Policies
    6. Regulatory Scenario
    7. Overview of Novel Approaches to Treat Dry Eyes
    8. Key Industry Trends
    9. Healthcare Industry Overview
    10. Impact of COVID-19 on the U.S. Dry Eye Syndrome Market
    11. Overview of Over the Counter Eye Lubricants In the Market
  5. U.S. Dry Eye Syndrome Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Anti-inflammatory
        1. Cyclosporine
        2. Corticosteroids
        3. Others
      2. Artificial Tears and Lubricants
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Alcon
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Santen Pharmaceutical Co., Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. OASIS Medical
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Otsuka Pharmaceutical Co., Ltd. (Otsuka Holdings, Co., Ltd)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. VISUfarma
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Dry Eye Disease in the U.S., 2022
    2. Key Industry Developments
    3. Pipeline Analysis
    4. New Product Launches
    5. Reimbursement Policies
    6. Regulatory Scenario
    7. Overview of Novel Approaches to Treat Dry Eyes
    8. Key Industry Trends
    9. Healthcare Industry Overview
    10. Impact of COVID-19 on the U.S. Dry Eye Syndrome Market
    11. Overview of Over the Counter Eye Lubricants In the Market
  5. U.S. Dry Eye Syndrome Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product
      1. Anti-inflammatory
        1. Cyclosporine
        2. Corticosteroids
        3. Others
      2. Artificial Tears and Lubricants
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospitals Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. AbbVie Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Alcon
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Santen Pharmaceutical Co., Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. OASIS Medical
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Sun Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Otsuka Pharmaceutical Co., Ltd. (Otsuka Holdings, Co., Ltd)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. VISUfarma
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  U.S. Dry Eye Syndrome Market Value Share (%), By Product, 2022 & 2030

Figure 2: U.S. Dry Eye Syndrome Market Value Share (%), By Distribution Channel, 2022 & 2030

Table 1: U.S. Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Product, 2019-2030

Table 2:  U.S. Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Anti-inflammatory, 2019-2030

Table 3: U.S. Dry Eye Syndrome Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

U.S. Dry Eye Syndrome Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 100
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports